PDD $63.11 -3.161%
BELR.BR $7.50 0%
MPRA $10.44 0%
CGW.L $28.00 12%
WU $11.82 -1.2124%
C1U.PA $730.30 -0.1777%
FORG $20.06 -0.4467%
1330.HK $2.82 -2.7586%
CCPC.L $190.00 -7.76699%
EFOI $0.46 0.6637%
1415.HK $16.74 2.3227%
FIPP.PA $0.12 0%
LQGH.L $4.33 -0.2535%
C2U.PA $6.38 -0.3127%
NICL.L $1 040.00 0.4831%
ADF $10.66 0%
BOOST.PA $1.38 0%
VVI $21.73 1.211%
1713.HK $1.75 0%
UCBIO $16.92 -2.6467%
EDEN.PA $59.04 0.7509%
EMHD.PA $21.47 -0.5328%
PIN $21.57 -0.2082%
TDG $786.69 -1.2787%
RNR-PE $25.24 0%
CLIX $32.59 -0.7477%
FCSH $23.65 0%
3628.HK $0.12 0%
0L8A.L $73.31 -1.9763%
CVNA $10.66 -10.8696%
MLIFC.PA $2.00 0%
GLMD $0.33 -11.2104%
8532.HK $0.04 8.3333%
FOX.L $1.09 0%
ISXF.L $103.59 -0.3703%
HAYN $43.98 0.0227%
MIND $0.41 -2.8206%
SITC-PA $24.25 -0.0824%
PCTI $4.91 1.2371%
JHD.L $215.00 4.3689%
FIZZ $51.49 -0.5697%
JHML $51.32 -0.4034%
0P0000KM1W.L $21 362.50 -0.0734%
SDI.L $150.00 0%
PATH $14.22 -2.7036%
1958.HK $2.28 -2.5641%
CBAV3.SA $4.89 0.2049%
AN $131.42 -0.8974%
0IP9.L $119.45 0.0009%
NFL3.L $0.24 1.7241%
QS $5.83 -3.3168%
BHSEU $12.96 0%
GILI.L $14 498.00 -1.1421%
0P000147Q9.L $9 441.97 0.8283%
MBI $7.83 3.2322%
VCR $249.05 -1.2881%
CDE $3.32 -3.6337%
SRET $21.00 -0.9794%
EIM $10.08 0.0993%
NFBK $9.29 0.1078%
0230.HK $0.49 2.0833%
CLDS $38.51 0%
ROTH.PA $47.35 -0.1055%
V2Y.SI $0.02 0%
0282.HK $0.29 0%
0EDD.L $89.44 0.9237%
RADL3.SA $27.89 0.0359%
VAPX.L $19.76 -0.221%
EBIX $15.43 0.9156%
NTLA $43.10 -3.4065%
1520.HK $0.21 -2.3148%
0519.HK $0.06 3.5714%
AKW.PA $14.34 0.7022%
IMAC $1.01 250.573%
DESP $5.51 -2.7385%
EALT3.SA $8.90 8.5366%
LIDR $0.19 -9.6588%
XCLR $24.97 0%
2885.HK $0.31 -8.8235%
ETL.PA $6.33 -0.3152%
SUNW $0.88 1.7606%
THRY $21.21 1.0243%
1321.HK $0.95 -2.0619%
CYTO $0.93 -5.9596%
BSJN $23.55 -0.0679%
ME $2.02 -4.0476%
SAE.L $1.08 0%
BRSH $0.33 6.4537%
WALA $25.37 0%
0599.HK $0.18 0%
AEMB $37.79 0.3319%
IGLA.L $4.60 -0.4706%
FSLR $226.96 23.8905%
0KSA.L $22.67 -1.0013%
QUMU $0.90 0%
JAM.L $711.00 -0.2805%
SPEC.L $130.50 -2.6119%
REET $22.78 -1.1285%
Eng
Логотип
Eng
Лого

bioMérieux S.A. BIM.PA

$97.12

+$1.26 (1.29%)
На 18:01, 12 мая 2023

Ранг: 2

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    11308662480.00000000

  • week52high

    109.20

  • week52low

    77.48

  • Revenue

    3589000000

  • P/E TTM

    26

  • Beta

    0.12213700

  • EPS

    3.81000000

  • Last Dividend

    0.85000000

  • Next Earnings Date

    27 апр 2023 г. в 10:59

Описание компании

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек